Development and validation of nomograms integrating immune‐related genomic signatures with clinicopathologic features to improve prognosis and predictive value of triple‐negative breast cancer: A gene expression‐based retrospective study

PURPOSE: Accumulating evidence indicated that triple‐negative breast cancer (TNBC) can stimulate stronger immune responses than other subtypes of breast cancer. We hypothesized that integrating immune‐related genomic signatures with clinicopathologic factors may yield a predictive accuracy exceeding...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kang, Li, Hai‐Lin, Xiong, Yong‐Fu, Shi, Yang, Li, Zhu‐Yue, Li, Jie, Zhang, Xiang, Li, Hong‐Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382728/
https://www.ncbi.nlm.nih.gov/pubmed/30677255
http://dx.doi.org/10.1002/cam4.1880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382728/
https://www.ncbi.nlm.nih.gov/pubmed/30677255
http://dx.doi.org/10.1002/cam4.1880

Ejemplares similares